2025 ISAKOS Congress in Munich, Germany

ISAKOS 2025 Congress Faculty


Khay-Yong Saw, MB ChB, MCh Orth, FRCS(Edin)

Kuala Lumpur Sports Medicine Centre
Kuala Lumpur MALAYSIA

Dr. Khay-Yong SAW is the founder and a Consultant Orthopaedic Surgeon at the Kuala Lumpur Sports Medicine Centre in Kuala Lumpur, Malaysia. He graduated from Liverpool University Medical School in 1984, obtained his FRCS in Edinburgh in 1989 and went on to his chosen field which was Orthopaedic Surgery. In 1993, he completed his Masters in Orthopaedic Surgery (MCh Orth) at the Liverpool University Medical School, UK. His specialization in orthopaedic sports medicine includes knee joint arthroscopic surgery with application of stem cells for chondrogenesis together with bone and soft tissue regeneration. In Year 2005, he started his research work in Articular Cartilage Regeneration with the use of stem cells. This pioneering technology enables the restoration of damaged cartilage to its original state. He continues to further his research in articular cartilage regeneration and has completed a Phase2b multicentre US-FDA trial. He has presented his work at numerous scientific meetings, published peer reviewed journals on stem cells related work and received awards on knee cartilage regeneration. Dr Saw also has several patents granted for this method of chondrogenesis in the knee and on his novel medical device plus procedure in knee osteotomy.
www.klsmc.com

ePosters
Biologics
E-Poster
Articular Cartilage Regeneration with Autologous Peripheral Blood Stem Cells and Adjuvant Hyaluronic Acid: An Animal Study in Sheep Model
Presenting Author

Disclosures

Royalties received from No
Speaker for No
Employee of No
Paid Consultant for No
Unpaid Consultant for No
Stock received from No
Support received from No
Financial Support received from No
Royalties or support received from No
Editorial or Governing board of No
Board of Directors member for Board of Directors of Kuala Lumpur Sports Medicine Centre and KLSMC Stem Cells
The content of this individual's activity is unrelated to promotion of the business lines or products of this individual's employer.
All relevant financial disclosures have been mitigated.
Disclosures complete: Sep 12, 2022

*Please note that Global Link resources are not part of the CME offered for the 2025 ISAKOS Congress.